Page last updated: 2024-08-21

hydrazine and Breast Neoplasms

hydrazine has been researched along with Breast Neoplasms in 67 studies

Research

Studies (67)

TimeframeStudies, this research(%)All Research%
pre-199017 (25.37)18.7374
1990's3 (4.48)18.2507
2000's9 (13.43)29.6817
2010's32 (47.76)24.3611
2020's6 (8.96)2.80

Authors

AuthorsStudies
Chernoburova, EI; Ilovaisky, AI; Merkulova, VM; Salnikova, DI; Scherbakov, AM; Shchetinina, MA; Terent'ev, AO; Zavarzin, IV1
Li, S; Shi, Y; Xu, S1
Banerjee, S; Banik, D; Halder, S; Jana, K; Karak, A; Mahapatra, AK; Maiti, A; Mandal, M1
Jin, Y; Liu, B; Tang, C; Tian, E; Tong, H; Wang, F; Wang, X1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Di, G; Fan, J; Guo, C; Li, Q; Wang, J; Wang, L; Wu, X; Zhang, F1
Afsharinasab, A; Almasirad, A; Amanzadeh, A; Dehghani, S; Kooshafar, Z; Mousavi, E; Salimi, M; Shafiee, S; Tavakolfar, S1
Botelho, FV; Campos, DL; Da Costa Ferreira, AM; Deflon, VM; Guerra, W; Guilardi, S; Jaimes, EHL; Maia, PIDS; Marzano, IM; Paixão, DA; Pavan, FR; Pereira-Maia, EC; Pivatto, M; Silva, MJB; Uehara, IA1
Chalmers, JJ; Lustberg, M; Miller, B; Summers, TA1
Li, W; Liu, WY; Xu, WZ; Yang, YT; Zhou, TT1
Qi, Y; Qiao, Q; Qin, X; Song, Q; Wu, T; Yang, C; Zhang, Z1
Abedi, SM; Ahmadpour, S; Hosseinimehr, SJ; Noaparast, Z1
Kaake, M; Low, PS; Roy, J; Srinivasarao, M1
Alshaker, H; Low, CMR; Monteil, D; Pchejetski, D; Srivats, S; Wang, Q1
Chakraborty, S; Chakravarty, R; Das, S; Dash, A; Mittal, BR; Sarma, HD; Shukla, J; Vatsa, R1
Cai, X; Cao, H; Chen, T; Dang, W; Tang, H; Tian, W; Wang, L; Wang, X; Zhang, X1
Estrada, G; Ferro-Flores, G; García-Becerra, R; Gómez-Argumosa, E; Izquierdo-Sánchez, V; Ocampo-García, BE; Ortiz-Arzate, Z; Santos-Cuevas, CL1
Fan, J; Mu, H; Peng, X; Wang, J; Zhu, H1
Cheng, PC; Chiang, PF; Chuang, TW; Lin, WJ; Luo, TY; Yeh, CH1
Capasso, A; Caruso, A; Lancelot, JC; Lappano, R; Maggiolini, M; Panno, A; Pisano, A; Rault, S; Rosano, C; Santolla, MF; Saturnino, C; Sinicropi, MS1
Cardoso, VN; Coelho, MM; Corrêa, NC; De Barros, AL; De Góes, AM; Mota, LD; Oliveira, MC1
Cao, X; Fu, P; Li, L; Tian, L; Xu, P; Zhao, C1
Aiello, F; Andò, S; Badolato, M; Barone, I; Bonofiglio, D; Brancale, A; Cancellieri, M; Catalano, S; Chemi, F; Garofalo, A; Giordano, C; Grande, F; Vircillo, V1
Ajees, AA; Biswas, S; Kamath, PR; Pai, KS; Sunil, D1
Hayama, K; Kawase, T; Tsubokawa, N; Tsuchimochi, M; Yamaguchi, H1
Grayton, JE; Miller, T; Wilson-Robles, H1
Chen, YC; Hou, WC; Juan, SH; Ko, CH; Lin, CW; Shen, SC; Wang, LM1
Kamihashi, J; Kuge, Y; Ogawa, Y; Saji, H; Sano, K; Takai, N; Temma, T1
Barsoum, J; Cui, X; Giuliano, A; Liu, B; Qu, Y; Sim, MS; Wang, J1
Farghaly, TA; Gomha, SM; Riyadh, SM1
Chen, W; Cheng, R; Deng, C; Liu, H; Lu, W; Meng, F; Wang, Z; Zhan, F; Zhong, Z1
Al-Qasoumi, SI; Al-Said, MS; Bashandy, MS; Ghorab, MM1
Chen, T; Feng, W; Tian, W; Wang, X; Zhang, X; Zhang, Y1
Esteva, FJ; Song, J; Tian, Y; Zhang, H1
Alli, E; Ford, JM1
Cavallaro, G; Celia, C; Fresta, M; Giammona, G; Licciardi, M; Paolino, D1
Antunes, F; Barazarte, A; Camacho, J; Charris, J; Gamboa, N; Rodrigues, JR1
Erickson-Miller, CL; Figueroa, DJ; Kamel, YM; Kirchner, J; Liu, Y; Martin, AM; Messam, C; Ottesen, L; Pillarisetti, K1
Chandra, P; Shim, YB; Zhu, Y1
Chumsri, S; Zimrin, A1
Arterburn, JB; Carlson, KE; Corona, C; Katzenellenbogen, JA; Rao, KV1
BROWN, PS; CROOKS, J; KLOPPER, AI; THORBURN, AR; TULLOCH, MI1
GRUENSTEIN, M; SHAY, H; SHIMKIN, MB1
DREWS, J; FOELSCH, E; GRUNZE, H1
Chaudhuri, G; Pervin, S; Singh, R1
Loo, G; Takahashi, K1
Colella, S; Johnson, MM; Krahe, R; Mora, E; Simeone, AM; Tari, AM1
Buckiová, D; Kren, V; Peknicová, J; Simánek, V; Ulrichová, J; Valentová, K1
Fu, P; Li, Z; Sheng, Y; Zhao, C1
Biggerstaff, J; Kabalka, G; Le Puil, M; Miao, W; Townsend, D; Wall, J; Yao, ML; Zeng, W1
Regelson, W1
Brooks, SA; Dwek, MV; Harvey, DJ; Leathem, AJ; Streets, AJ1
Holzman, D1
Lane, K; Marshall, K; Senior, J1
Jenner, PG; Jones, MK; Ramsay, ID1
Kühböck, J; Mannheimer, E; Pietschmann, H1
Kokron, O; Letnansky, K; Titscher, R1
Pergola, M; Perrone, V; Zarrilli, D1
el-Akkad, SM; Garrett, MJ; Glazebrook, GA; Shakir, MA1
Derriks, R; Heynen, E; Mannes, P; Moens, R1
Connors, TA1
Alberto, P1
Bernard, E; Israel, L1
Kohout, J1
Backhouse, TW; Sicher, K1
Jelliffe, AM1

Reviews

1 review(s) available for hydrazine and Breast Neoplasms

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021

Trials

2 trial(s) available for hydrazine and Breast Neoplasms

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
The 'grand conspiracy' against the cancer cure.
    JAMA, 1980, Jan-25, Volume: 243, Issue:4

    Topics: Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Humans; Hydrazines; Intestinal Neoplasms; Neoplasms; Skin Neoplasms

1980

Other Studies

65 other study(ies) available for hydrazine and Breast Neoplasms

ArticleYear
Secosteroidal hydrazides: Promising scaffolds for anti-breast cancer agents.
    The Journal of steroid biochemistry and molecular biology, 2021, Volume: 214

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Hydrazines; Inhibitory Concentration 50; Lactones; Magnetic Resonance Spectroscopy; MCF-7 Cells; Molecular Structure; Steroids; Structure-Activity Relationship

2021
Selinexor improves the anti-cancer effect of tucidinostat on TP53 wild-type breast cancer.
    Molecular and cellular endocrinology, 2022, 04-05, Volume: 545

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydrazines; Mice; Mice, Nude; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2022
Switching to a 'turn-on' fluorescent probe for rapid detection of hydrazine in human breast cancer cells using a test-strip.
    Analytical methods : advancing methods and applications, 2022, 09-29, Volume: 14, Issue:37

    Topics: Breast Neoplasms; Female; Fluorescent Dyes; Humans; Hydrazines; Hydrazones; Spectrometry, Fluorescence

2022
Robust ERα-Targeted Near-Infrared Fluorescence Probe for Selective Hydrazine Imaging in Breast Cancer.
    Analytical chemistry, 2022, Oct-11, Volume: 94, Issue:40

    Topics: Breast Neoplasms; Estrogen Receptor alpha; Female; Fluorescent Dyes; Humans; Hydrazines; Spectrometry, Fluorescence

2022
Novel poly (ADP-ribose) polymerases inhibitor DHC-1 exhibits in vitro and in vivo anticancer activity on BRCA-deficient pancreatic cancer cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2021, Volume: 147

    Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Mice; Mice, Nude; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Thioamides; Xenograft Model Antitumor Assays

2021
In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells.
    Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Female; Furans; G1 Phase; Humans; Hydrazines; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred BALB C; Proto-Oncogene Proteins c-bcl-2; Thiophenes

2017
Novel copper(II) complexes with hydrazides and heterocyclic bases: Synthesis, structure and biological studies.
    Journal of inorganic biochemistry, 2017, Volume: 172

    Topics: Antineoplastic Agents; Antitubercular Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; Female; Heterocyclic Compounds; Humans; Hydrazines; Inhibitory Concentration 50; K562 Cells; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium

2017
Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1634

    Topics: Biomarkers, Tumor; Breast Neoplasms; Carbocyanines; Cell Count; Cell Line, Tumor; Epithelial Cell Adhesion Molecule; Female; Fluorescent Dyes; Humans; Hydrazines; Image Processing, Computer-Assisted; Indoles; Keratins; Leukocyte Common Antigens; Leukocytes, Mononuclear; Liquid Crystals; Neoplastic Cells, Circulating; Optical Imaging; Software; Succinimides

2017
A novel fluorescein-based "turn-on" probe for the detection of hydrazine and its application in living cells.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2018, Mar-15, Volume: 193

    Topics: Breast Neoplasms; Female; Fluorescein; Fluorescent Dyes; Humans; Hydrazines; Limit of Detection; Molecular Imaging; Spectrometry, Fluorescence; Tumor Cells, Cultured

2018
Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
    Molecular pharmaceutics, 2018, 03-05, Volume: 15, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Hydrazines; Indazoles; Lung; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Nanomedicine; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tissue Distribution; Treatment Outcome; Vitamin E; Xenograft Model Antitumor Assays

2018
    Anti-cancer agents in medicinal chemistry, 2018, Volume: 18, Issue:9

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Female; Glycine; Humans; Hydrazines; MCF-7 Cells; Mice, Nude; Niacinamide; Oligopeptides; Radionuclide Imaging; Radiopharmaceuticals; Technetium

2018
Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers.
    Bioconjugate chemistry, 2018, 07-18, Volume: 29, Issue:7

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Delivery Systems; Endometrial Neoplasms; Female; Heterografts; Humans; Hydrazines; Male; Mice; Oligopeptides; Ovarian Neoplasms; Pipecolic Acids; Prostatic Neoplasms; Receptors, LHRH; Thymine

2018
Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.
    Breast cancer research and treatment, 2018, Volume: 172, Issue:1

    Topics: Amino Alcohols; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cell-Free System; Docetaxel; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Hydrazines; Ligands; Mice; Models, Molecular; Phosphotransferases (Alcohol Group Acceptor); Pyrazoles; Xenograft Model Antitumor Assays

2018
An improved kit formulation for one-pot synthesis of [
    Journal of labelled compounds & radiopharmaceuticals, 2019, Volume: 62, Issue:12

    Topics: Adult; Aged; Animals; Breast Neoplasms; Chemistry Techniques, Synthetic; Female; Half-Life; Humans; Hydrazines; Melanoma; Mice; Middle Aged; Nicotinic Acids; Organotechnetium Compounds; Peptides, Cyclic; Radiochemistry; Single Photon Emission Computed Tomography Computed Tomography; Tissue Distribution

2019
Hydrazinocurcumin Encapsuled nanoparticles "re-educate" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Survival; Curcumin; Female; Flow Cytometry; Hydrazines; Macrophages; Mice; Mice, Inbred BALB C; Nanoparticles; STAT3 Transcription Factor

2013
Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Nuclear medicine communications, 2014, Volume: 35, Issue:4

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Dimerization; Edetic Acid; Female; Freeze Drying; Humans; Hydrazines; Mice; Nicotinic Acids; Oligopeptides; Organotechnetium Compounds; Radiochemistry; Radiometry; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2014
An "enhanced PET"-based fluorescent probe with ultrasensitivity for imaging basal and elesclomol-induced HClO in cancer cells.
    Journal of the American Chemical Society, 2014, Sep-17, Volume: 136, Issue:37

    Topics: Animals; Antineoplastic Agents; Boron Compounds; Breast; Breast Neoplasms; Chlorocebus aethiops; COS Cells; Female; Fluorescent Dyes; Humans; Hydrazines; Hypochlorous Acid; MCF-7 Cells; Optical Imaging; Positron-Emission Tomography

2014
188Re-HYNIC-trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells.
    Annals of nuclear medicine, 2015, Volume: 29, Issue:1

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Flow Cytometry; Humans; Hydrazines; Membrane Potential, Mitochondrial; Nicotinic Acids; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Trastuzumab

2015
(6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells.
    Current topics in medicinal chemistry, 2015, Volume: 15, Issue:11

    Topics: Binding Sites; Breast Neoplasms; Carbazoles; Cell Line, Tumor; Female; Humans; Hydrazines; MCF-7 Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Docking Simulation; Phosphorylation; Receptors, Estrogen; Receptors, G-Protein-Coupled

2015
Bombesin Encapsulated in Long-Circulating pH-Sensitive Liposomes as a Radiotracer for Breast Tumor Identification.
    Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:2

    Topics: Animals; Bombesin; Breast Neoplasms; Drug Compounding; Female; Humans; Hydrazines; Hydrogen-Ion Concentration; Liposomes; Mice; Mice, Inbred C57BL; Mice, Nude; Nicotinic Acids; Organotechnetium Compounds; Peptide Fragments; Radioactive Tracers; Radionuclide Imaging; Tumor Cells, Cultured

2015
Imaging CXCR4 Expression with (99m)Tc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts.
    Molecular imaging and biology, 2016, Volume: 18, Issue:3

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Hydrazines; Mice, Inbred BALB C; Molecular Imaging; Nicotinic Acids; Oligonucleotides, Antisense; Radiopharmaceuticals; Receptors, CXCR4; RNA, Small Interfering; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays

2016
Identification of novel 2-(1H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motility.
    Future medicinal chemistry, 2016, Volume: 8, Issue:2

    Topics: Antineoplastic Agents; Binding Sites; Breast Neoplasms; Catalytic Domain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Drug Design; Female; Humans; Hydrazines; Ligands; Molecular Docking Simulation; Receptors, CXCR4; Signal Transduction

2016
N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential.
    European journal of medicinal chemistry, 2016, Sep-14, Volume: 120

    Topics: Apoptosis; bcl-X Protein; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; Humans; Hydrazines; Molecular Docking Simulation; Neoplasm Metastasis; Proto-Oncogene Proteins c-bcl-2

2016
Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
    International journal of molecular sciences, 2016, Jul-07, Volume: 17, Issue:7

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Hydrazines; Immunohistochemistry; Indocyanine Green; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Multimodal Imaging; Nanoparticles; Polyamines; Radiopharmaceuticals; Receptor, ErbB-2; Silicon Dioxide; Spectroscopy, Near-Infrared; Technetium; Transplantation, Heterologous

2016
In vitro evaluation of Selective Inhibitors of Nuclear Export (SINE) drugs KPT-185 and KPT-335 against canine mammary carcinoma and transitional cell carcinoma tumor initiating cells.
    Veterinary and comparative oncology, 2017, Volume: 15, Issue:4

    Topics: Acrylamides; Acrylates; Active Transport, Cell Nucleus; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Nucleus; Dog Diseases; Dogs; Female; Hydrazines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles

2017
Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.
    Carcinogenesis, 2008, Volume: 29, Issue:9

    Topics: Biphenyl Compounds; Breast Neoplasms; Carcinogens; Cell Movement; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Hydroxyl Radical; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Picrates; Protein Kinase C-delta; Quercetin; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription, Genetic

2008
Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Diagnostic Techniques, Radioisotope; Female; Hydrazines; Matrix Metalloproteinase 14; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nicotinic Acids; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Technetium

2009
Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells.
    Breast cancer research and treatment, 2010, Volume: 121, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Separation; Doxorubicin; Drug Synergism; Female; Flow Cytometry; Humans; Hydrazines; JNK Mitogen-Activated Protein Kinases; Paclitaxel; Proto-Oncogene Proteins c-akt; Signal Transduction

2010
Novel polyazaheterocyclic systems: Synthesis, antitumor, and antimicrobial activities.
    Archives of pharmacal research, 2010, Volume: 33, Issue:11

    Topics: Amines; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Fungi; HeLa Cells; Hep G2 Cells; Heterocyclic Compounds; Humans; Hydrazines; Hydroxylamine; Microbial Sensitivity Tests; Molecular Structure

2010
Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Biomacromolecules, 2011, Oct-10, Volume: 12, Issue:10

    Topics: Acids; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Endocytosis; Endosomes; Female; Humans; Hydrazines; Hydrogen-Ion Concentration; Macrophages; Magnetic Resonance Spectroscopy; Mice; Micelles; Molecular Targeted Therapy; Polyethylene Glycols; Polymethacrylic Acids; Prodrugs

2011
Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:9

    Topics: Antineoplastic Agents; Benzopyrans; Breast Neoplasms; Cell Line, Tumor; Dihydropyridines; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Hydrazines; Indicators and Reagents; Magnetic Resonance Spectroscopy; Spectrophotometry, Infrared; Structure-Activity Relationship; Sulfones

2011
The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.
    International journal of oncology, 2012, Volume: 40, Issue:4

    Topics: Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Cycle Checkpoints; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Cell Survival; Curcumin; Dose-Response Relationship, Drug; Female; Humans; Hydrazines; Phosphorylation; STAT3 Transcription Factor

2012
Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry.
    Molecular & cellular proteomics : MCP, 2012, Volume: 11, Issue:6

    Topics: Amino Acid Sequence; Breast Neoplasms; Chromatography, Affinity; Female; Gene Expression; Glycoproteins; Humans; Hydrazines; Lymphatic Metastasis; Molecular Sequence Data; N-Acetylneuraminic Acid; Orosomucoid; Peptide Fragments; Proteomics; Solid Phase Extraction; Tandem Mass Spectrometry; Tissue Array Analysis; Versicans

2012
Breast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol.
    DNA repair, 2012, May-01, Volume: 11, Issue:5

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; DNA Damage; DNA Repair; Female; Genes, BRCA1; Humans; Hydrazines; Mice; Mutation; Reactive Oxygen Species; Receptor, ErbB-2

2012
Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2012, Volume: 82, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Gemcitabine; Humans; Hydrazines; Liposomes; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Nylons; Xenograft Model Antitumor Assays

2012
Cytotoxic effects of N'-formyl-2-(5-nitrothiophen-2-yl) benzothiazole-6-carbohydrazide in human breast tumor cells by induction of oxidative stress.
    Anticancer research, 2012, Volume: 32, Issue:7

    Topics: Adenocarcinoma; Antineoplastic Agents; Antioxidants; Benzothiazoles; Breast Neoplasms; Catalase; Cell Line, Tumor; Female; Glutathione; Glutathione Reductase; Glutathione Transferase; Humans; Hydrazines; Lipid Peroxidation; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase

2012
Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.
    BMC cancer, 2012, Sep-11, Volume: 12

    Topics: Benzoates; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Inhibitory Concentration 50; Lung Neoplasms; Male; Ovarian Neoplasms; Pyrazoles; Receptors, Thrombopoietin

2012
Ultrasensitive and selective electrochemical diagnosis of breast cancer based on a hydrazine-Au nanoparticle-aptamer bioconjugate.
    Analytical chemistry, 2013, Jan-15, Volume: 85, Issue:2

    Topics: Aptamers, Nucleotide; Biosensing Techniques; Breast Neoplasms; Cells, Cultured; Electrochemical Techniques; Female; Gold; HeLa Cells; Humans; Hydrazines; MCF-7 Cells; Metal Nanoparticles; Receptor, ErbB-2

2013
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
    Annals of hematology, 2013, Volume: 92, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoates; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Resistance; Female; Humans; Hydrazines; Mastectomy, Segmental; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Estrogen; Receptors, Fc; Recombinant Fusion Proteins; Remission Induction; Splenectomy; Taxoids; Thrombocytopenia; Thrombopoietin

2013
Synthesis of 17-alpha-substituted estradiol-pyridin-2-yl hydrazine conjugates as effective ligands for labeling with Alberto's complex fac-[Re(OH2)3(CO)3]+ in water.
    The Journal of organic chemistry, 2003, Sep-05, Volume: 68, Issue:18

    Topics: Animals; Breast Neoplasms; Estradiol; Female; Humans; Hydrazines; In Vitro Techniques; Indicators and Reagents; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pyridines; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Estrogen; Sheep; Technetium; Trisaccharides; Uterus; Water

2003
SOME ENDOCRINOLOGICAL EFFECTS OF A DITHIOCARBAMOYLHYDRAZINE.
    British medical journal, 1963, Dec-28, Volume: 2, Issue:5373

    Topics: Breast Neoplasms; Exophthalmos; Female; Geriatrics; Gonadotropins; Gonadotropins, Pituitary; Humans; Hydrazines; Pituitary Diseases; Pituitary Gland; Thyroid Gland; Toxicology; Uterine Prolapse

1963
INHIBITION OF MAMMARY CANCER IN RATS BY A DITHIOCARBAMOYLHYDRAZINE (ICI-33,828).
    Cancer research, 1964, Volume: 24

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Castration; Female; Humans; Hydrazines; Male; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Methallibure; Methylcholanthrene; Orchiectomy; Ovary; Pharmacology; Rats; Research

1964
[ON THE EFFECT OF A NEW CYTOSTATIC (RO-4-6467) ON THE INCORPORATION OF LABELLED GLYCINE IN TUMOR CELLS].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1964, Volume: 70

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cytostatic Agents; Glycine; Humans; Hydrazines; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Research

1964
Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt.
    Cancer research, 2003, Sep-01, Volume: 63, Issue:17

    Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cytochrome c Group; Cytosol; Humans; Hydrazines; Intracellular Membranes; Membrane Potentials; Mitochondria; Nitric Oxide Donors; Nitroso Compounds; Oligonucleotides, Antisense; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured

2003
Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells.
    Biochemical pharmacology, 2004, Jan-15, Volume: 67, Issue:2

    Topics: Annexin A5; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspases; Chromatin; Cytochromes c; DNA Fragmentation; Humans; Hydrazines; Matrix Metalloproteinases; Membrane Potentials; Mitochondria; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tocotrienols; Tumor Cells, Cultured

2004
N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
    Carcinogenesis, 2006, Volume: 27, Issue:3

    Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Enzyme Induction; Female; Fenretinide; Humans; Hydrazines; Neoplasm Invasiveness; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrogen Oxides; Tumor Cells, Cultured

2006
The in vitro biological activity of Lepidium meyenii extracts.
    Cell biology and toxicology, 2006, Volume: 22, Issue:2

    Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Estrogens; Fatty Acids; Hepatocytes; Humans; Hydrazines; Lepidium; Male; Picrates; Plant Extracts; Rats; Rats, Wistar; Steroids

2006
The effect of Tc-99m-labeled MDM2 antisense oligonucleotide on gene expression in human breast cancer MCF-7 cells.
    Journal of experimental therapeutics & oncology, 2007, Volume: 6, Issue:4

    Topics: Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression; Genes, p53; Humans; Hydrazines; Isotope Labeling; Nicotinic Acids; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-mdm2; RNA, Messenger; Technetium; Tumor Suppressor Protein p53

2007
Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis.
    Bioorganic & medicinal chemistry letters, 2008, Jun-15, Volume: 18, Issue:12

    Topics: Apoptosis; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Cytoplasm; Dansyl Compounds; Female; Fluorine Radioisotopes; Humans; Hydrazines; Isotope Labeling; Molecular Structure; Molecular Weight; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stereoisomerism

2008
Oligosaccharide release from frozen and paraffin-wax-embedded archival tissues.
    Analytical biochemistry, 1996, Nov-01, Volume: 242, Issue:1

    Topics: Animals; Breast Neoplasms; Chromatography, Ion Exchange; Cryopreservation; Humans; Hydrazines; Liver; Oligosaccharides; ortho-Aminobenzoates; Paraffin Embedding; Retrospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Fixation

1996
Green tea, mistletoe, and more: Canadians test alternative cancer therapies.
    Journal of the National Cancer Institute, 1997, May-21, Volume: 89, Issue:10

    Topics: Antineoplastic Agents; Breast Neoplasms; Camphor; Canada; Complementary Therapies; Dehydroepiandrosterone; Humans; Hydrazines; Plant Extracts; Plant Proteins; Tea; Vitamins

1997
Growth inhibitory effects of thromboxane antagonists on breast cancer cell lines: a preliminary study.
    Advances in experimental medicine and biology, 1997, Volume: 400A

    Topics: Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Humans; Hydrazines; Phenylacetates; Prostaglandins, Synthetic; Sulfonamides; Thromboxanes; Tumor Cells, Cultured

1997
The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    British journal of clinical pharmacology, 1978, Volume: 5, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Carbidopa; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Hydrazines; Levodopa; Middle Aged; Prolactin; Thyroxine; Time Factors

1978
[Cytostatic therapy of hemoblastoses and malignant tumors with a methylhydrazine derivative].
    Wiener klinische Wochenschrift, 1966, Dec-02, Volume: 78, Issue:48

    Topics: Adolescent; Adult; Aged; Bone Marrow Examination; Breast Neoplasms; Carcinoma, Bronchogenic; Female; Hodgkin Disease; Humans; Hydrazines; Kidney Neoplasms; Leukemia; Lymphadenitis; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Sarcoma, Synovial

1966
Local therapy of malignant pleural effusions.
    Neoplasma, 1974, Volume: 21, Issue:4

    Topics: Animals; Breast Neoplasms; Bronchial Neoplasms; Cattle; Cyclophosphamide; Drug Combinations; Female; Glucose; Gold Isotopes; Humans; Hydrazines; L-Lactate Dehydrogenase; Lactates; Lung Neoplasms; Male; Mannitol; Muramidase; Neoplasm Metastasis; Pancreatic Extracts; Papain; Plant Extracts; Pleural Effusion; Pleural Neoplasms; Podophyllin; Proteins; Radioisotopes; Thymus Extracts; Time Factors

1974
[Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
    La Clinica terapeutica, 1966, Oct-31, Volume: 39, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Nasopharyngeal Neoplasms; Tonsillar Neoplasms

1966
Combination chemotherapy in malignant disease.
    Clinical radiology, 1971, Volume: 22, Issue:4

    Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Injections, Intravenous; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Multiple Myeloma; Neoplasms; Prednisolone; Radiography; Remission, Spontaneous; Sarcoma, Ewing; Vinblastine

1971
[Antineoplastic polychemotherapy in thoracic pathology].
    Le Poumon et le coeur, 1968, Volume: 24, Issue:1

    Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclophosphamide; Drug Synergism; Ethinyl Estradiol; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Hydrazines; Hypophysectomy; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Melphalan; Mesothelioma; Methotrexate; Middle Aged; Nandrolone; Neoplasm Metastasis; Ovarian Neoplasms; Podophyllin; Sarcoma; Thiotepa; Vinblastine

1968
Cytotoxic agents in the treatment of malignant disease.
    British medical journal, 1968, Nov-16, Volume: 4, Issue:5628

    Topics: Antimetabolites; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Chlorambucil; Choriocarcinoma; Cyclophosphamide; Female; Fluorouracil; Hodgkin Disease; Humans; Hydrazines; Intestinal Neoplasms; Melphalan; Methotrexate; Multiple Myeloma; Ovarian Neoplasms; Pregnancy; Thiotepa; Vinblastine

1968
An outline of cancer chemotherapy.
    Revue roumaine d'inframicrobiologie, 1971, Volume: 8, Issue:3

    Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Asparaginase; Breast Neoplasms; Cells, Cultured; Colonic Neoplasms; Cricetinae; DNA, Neoplasm; Humans; Hydrazines; Hydroxyurea; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Mitomycins; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Rats; Ribonucleotides; Ribosomes; RNA, Neoplasm; Transplantation, Heterologous

1971
[Antitumor polychemotherapy].
    Le Poumon et le coeur, 1968, Volume: 24, Issue:1

    Topics: Adult; Antimetabolites; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Chlorambucil; Cyclophosphamide; Drug Synergism; Female; Fluorouracil; Humans; Hydrazines; Hydroxyprogesterones; Injections, Intramuscular; Injections, Intravenous; Medroxyprogesterone; Methotrexate; Nitrogen Mustard Compounds; Ovarian Neoplasms; Progestins

1968
[218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
    Le Poumon et le coeur, 1968, Volume: 24, Issue:1

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Drug Synergism; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Hydrazines; Injections, Intramuscular; Injections, Intravenous; Lectins; Lung Neoplasms; Mechlorethamine; Mercaptopurine; Methotrexate; Mouth Neoplasms; Neoplasm Metastasis; Pharyngeal Neoplasms; Urogenital Neoplasms; Vinblastine

1968
[Clinical experiences with the cytostatic drug natulan].
    Medizinische Klinik, 1969, May-09, Volume: 64, Issue:19

    Topics: Adenocarcinoma; Adult; Aged; Amides; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lung Neoplasms; Lymphoma, Non-Hodgkin; Macrophages; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Radiography

1969
Initial experiences with methylhydrazine, a new cytotoxic agent.
    Clinical radiology, 1966, Volume: 17, Issue:2

    Topics: Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Ovarian Neoplasms; Rectal Neoplasms; Retroperitoneal Neoplasms; Uterine Cervical Neoplasms

1966
Hodgkin's disease and some solid tumours.
    Proceedings of the Royal Society of Medicine, 1966, Volume: 59, Issue:12

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Chlorambucil; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Male; Middle Aged; Nitrogen Mustard Compounds; Steroids; Vinblastine

1966